Hyriavenko Natalia, Lyndin Mykola, Sikora Kateryna, Piddubnyi Artem, Karpenko Ludmila, Kravtsova Olha, Hyriavenko Dmytrii, Diachenko Olena, Sikora Vladyslav, Romaniuk Anatolii
Department of Pathology, Sumy State University, Sumy, Ukraine.
Sumy Regional Clinical Perinatal Center, Sumy, Ukraine.
J Pathol Transl Med. 2019 Jul;53(4):236-243. doi: 10.4132/jptm.2019.03.21. Epub 2019 Apr 11.
Although primary cancer of the fallopian tubes is a relatively rare type of tumor in female reproductive organs, its mortality is quite high. It is important to identify molecular and biological markers of this malignancy that determine its specific phenotype.
The study was carried out on samples received from 71 female patients with primary cancer of the fallopian tubes. The main molecular and biological properties, including hormone status (estrogen receptor [ER], progesterone receptor [PR]), human epidermal growth factor receptor (HER2)/neu expression, proliferative potential (Ki-67), apoptosis (p53, Bcl-2), and pro-angiogenic (vascular endothelial growth factor) quality of serous tumors were studied in comparison with clinical and morphological characteristics.
ER and PR expression is accompanied by low grade neoplasia, early clinical disease stage, and absence of lymphogenic metastasis (p < .001). HER2/neu expression is not typical for primary cancer of the fallopian tubes. Ki-67 expression is characterized by an inverse correlation with ER and PR (p < .05) and is associated with lymphogenic metastasis (p < .01). p53+ status correlates with high grade malignancy, tumor progression, metastasis, negative ER/PR (p < .001), and negative Bcl-2 status (p < .05). Positive Bcl-2 status is positively correlated with ER and PR expression and low grade malignancy.
Complex morphologic (histological and immunohistochemical) study of postoperative material allows estimation of the degree of malignancy and tumor spread to enable appropriate treatment for each case.
尽管原发性输卵管癌在女性生殖器官肿瘤中相对少见,但其死亡率相当高。识别决定这种恶性肿瘤特定表型的分子和生物学标志物很重要。
对71例原发性输卵管癌女性患者的样本进行研究。将浆液性肿瘤的主要分子和生物学特性,包括激素状态(雌激素受体[ER]、孕激素受体[PR])、人表皮生长因子受体(HER2)/neu表达、增殖潜能(Ki-67)、凋亡(p53、Bcl-2)以及促血管生成(血管内皮生长因子)特性,与临床和形态学特征进行比较研究。
ER和PR表达与低级别肿瘤形成、早期临床疾病阶段以及无淋巴转移相关(p <.001)。HER2/neu表达在原发性输卵管癌中不常见。Ki-67表达的特征是与ER和PR呈负相关(p <.05),并与淋巴转移相关(p <.01)。p53阳性状态与高级别恶性、肿瘤进展、转移、ER/PR阴性(p <.001)以及Bcl-2阴性状态(p <.05)相关。Bcl-2阳性状态与ER和PR表达以及低级别恶性呈正相关。
对术后材料进行复杂的形态学(组织学和免疫组织化学)研究,有助于评估恶性程度和肿瘤扩散情况,从而为每个病例制定合适的治疗方案。